Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan in pulmonary hypertension after LVAD implantation
NCT02554903Phase 2Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Mar 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of macitentan in pulmonary hypertension (PH), sponsored by Actelion Pharmaceuticals Ltd. Started Mar 2016; status: completed.
02
Drugs
macitentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02554903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554903.